Spinal technology firm VertiFlex opened a $5 million debt funding round, according to an SEC filing posted yesterday.
San Clemente, Calif.-based Vertiflex already raised most of the funds, pulling in $4.8 million with $200,000 left for the round.
The funding came from 7 unnamed investors this round, according to the filing. The company has not disclosed how the funds will be used.
In May, Vertiflex won pre-market approval from the FDA for its Superion interspinous spacer for treating moderate lumbar spinal stenosis.
VertiFlex’s device is designed to be implanted in the spine through a minimally invasive procedure to relieve pressure, the company. Spinal stenosis is a narrowing of the spine, which can put pressure on spinal nerves. The condition, which is often associated with aging, can cause pain, numbness and loss of certain motor function.